Methylome analysis identifies a Wilms tumor epigenetic biomarker detectable in blood

Genome Biology

Volumn 15, Issue 8, 2014, Pages

  Charlton, Jocelyn ^a   Williams, Richard D ^a   Weeks, Mark ^a   Sebire, Neil J ^a   Popov, Sergey ^b   Vujanic, Gordan ^c   Mifsud, William ^a   Alcaide German, Marisa ^a   Butcher, Lee M ^d   Beck, Stephan ^d   Pritchard Jones, Kathy ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLASTEMA; BLOOD ANALYSIS; CELL COMPOSITION; CHROMOSOMAL LOCALIZATION; CHROMOSOME 11; CHROMOSOME 6; CONTROLLED STUDY; CPG ISLAND; DNA SEQUENCE; EPIGENETICS; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METHYLATION; NEPHROBLASTOMA; ALGORITHM; BLOOD; CELL FREE SYSTEM; DNA METHYLATION; GENETIC EPIGENESIS; GENETICS; HUMAN GENOME; KIDNEY TUMOR; PATHOLOGY; PILOT STUDY;

TUMOR MARKER;

ALGORITHMS; BIOMARKERS, TUMOR; CELL-FREE SYSTEM; DNA METHYLATION; EPIGENESIS, GENETIC; GENOME, HUMAN; HUMANS; KIDNEY NEOPLASMS; PILOT PROJECTS; WILMS TUMOR;

EID: 84964314639     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/s13059-014-0434-y     Document Type: Article

References (48)

1. Breslow N, Olshan A, Beckwith JB, Green DM: Epidemiology of Wilms tumor. Med Pediatr Oncol 1993, 21:172.
2. Lemerle J, Voute PA, Tournade MF, Rodary C, Delemarre JF, Sarrazin D, Burgers JM, Sandstedt B, Mildenberger H, Carli M: Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial. J Clin Oncol 1983, 1:604.
3. Gautschi O, Bigosch C, Huegli B, Jermann M, Marx A, Chassé E, Ratschiller D, Weder W, Joerger M, Betticher DC, Stahel RA, Ziegler A: Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol 2004, 22:4157.
4. Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, Kinzler KW, Vogelstein B, Diaz LA Jr: Circulating mutant DNA to assess tumor dynamics. Nat Med 2008, 14:985.
5. Ramirez JL, Rosell R, Taron M, Sanchez-Ronco M, Alberola V, de las Peñas R, Sanchez JM, Moran T, Camps C, Massuti B, Sanchez JJ, Salazar F, Catot S: 14-3-3s Methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced Non-small-cell lung cancer patients predicts survival: the Spanish Lung Cancer Group. J Clin Oncol 2005, 23:9105.
6. Mori T, O'Day SJ, Umetani N, Martinez SR, Kitago M, Koyanagi K, Kuo C, Takeshima T-L, Milford R, Wang H-J, Vu VD, Nguyen SL, Hoon DSB: Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy. J Clin Oncol 2005, 23:9351.
7. Ruteshouser EC, Robinson SM, Huff V: Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors. Genes Chromosomes Cancer 2008, 47:461.
8. Scott RH, Murray A, Baskcomb L, Turnbull C, Loveday C, Al-Saadi R, Williams R, Breatnach F, Gerrard M, Hale J, Kohler J, Lapunzina P, Levitt GA, Picton S, Pizer B, Ronghe MD, Traunecker H, Williams D, Kelsey A, Vujanic GM, Sebire NJ, Grundy P, Stiller CA, Pritchard-Jones K, Douglas J, Rahman N: Stratification of Wilms tumor by genetic and epigenetic analysis. Oncotarget 2012, 3:327.
9. Chilukamarri L, Hancock AL, Malik S, Zabkiewicz J, Baker JA, Greenhough A, Dallosso AR, Huang TH, Royer-Pokora B, Brown KW, Malik K: Hypomethylation and aberrant expression of the glioma pathogenesis-related 1 gene in Wilms tumors. Neoplasia 2007, 9:970.
10. Hubertus J, Zitzmann F, Trippel F, Muller-Hocker J, Stehr M, von Schweinitz D, Kappler R: Selective methylation of CpGs at regulatory binding sites controls NNAT expression in Wilms tumors. PLoS One 2013, 8:e67605.
11. Malik K, Salpekar A, Hancock A, Moorwood K, Jackson S, Charles A, Brown KW: Identification of differential methylation of the WT1 antisense regulatory region and relaxation of imprinting in Wilms' tumor. Cancer Res 2000, 60:2356.
12. Ehrlich M, Hopkins NE, Jiang G, Dome JS, Yu MC, Woods CB, Tomlinson GE, Chintagumpala M, Champagne M, Dillerg L, Parham DM, Sawyer J: Satellite DNA hypomethylation in karyotyped Wilms tumors. Cancer Genet Cytogenet 2003, 141:97.
13. Ludgate JL, Le Mee G, Fukuzawa R, Rodger EJ, Weeks RJ, Reeve AE, Morison IM: Global demethylation in loss of imprinting subtype of Wilms tumor. Genes Chromosomes Cancer 2012, 52:174-184.
14. Zhang L, Anglesio MS, O'Sullivan M, Zhang F, Yang G, Sarao R, Mai PN, Cronin S, Hara H, Melnyk N, Li L, Wada T, Liu PP, Farrar J, Arceci RJ, Sorensen PH, Penninger JM: The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers. Nat Med 2007, 13:1060.
15. Wagner KJ, Cooper WN, Grundy RG, Caldwell G, Jones C, Wadey RB, Morton D, Schofield PN, Reik W, Latif F, Maher ER: Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer. Oncogene 2002, 21:7277.
16. Dallosso AR, Hancock AL, Szemes M, Moorwood K, Chilukamarri L, Tsai HH, Sarkar A, Barasch J, Vuononvirta R, Jones C, Pritchard-Jones K, Royer-Pokora B, Lee SB, Owen C, Malik S, Feng Y, Frank M, Ward A, Brown KW, Malik K: Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor. PLoS Genet 2009, 5:e1000745.
17. Rakyan VK, Beyan H, Down TA, Hawa MI, Maslau S, Aden D, Daunay A, Busato F, Mein CA, Manfras B, Dias KR, Bell CG, Tost J, Boehm BO, Beck S, Leslie RD: Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 2011, 7:e1002300.
18. Morris T, Butcher L, Feber A, Teschendorff A, Chakravarthy A, Wojdacz T, Beck S: 450 k Chip Analysis Methylation Pipeline (ChAMP). Bioinformatics 2013, 30:428-430.
19. Houseman EA, Molitor J, Marsit CJ: Reference-free cell mixture adjustments in analysis of DNA methylation data. Bioinformatics 2014, 30:1431.
20. Vujanic GM, Sandstedt B, Harms D, Kelsey A, Leuschner I, de Kraker J: Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. Med Pediatr Oncol 2002, 38:79.
21. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot CC Jr, Wright MW, Wain HM, Trowsdale J, Ziegler A, Beck S: Gene map of the extended human MHC. Nat Rev Genet 2004, 5:889.
22. de Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J, Ke X, Monsuur AJ, Whittaker P, Delgado M, Morrison J, Richardson A, Walsh EC, Gao X, Galver L, Hart J, Hafler DA, Pericak-Vance M, Todd JA, Daly MJ, Trowsdale J, Wijmenga C, Vyse TJ, Beck S, Murray SS, Carrington M, Gregory S, Deloukas P, Rioux JD: A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006, 38:1166.
23. Garrido C, Paco L, Romero I, Berruguilla E, Stefansky J, Collado A, Algarra I, Garrido F, Garcia-Lora AM: MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion, and intrinsic tumorigenicity of melanoma cells. Carcinogenesis 2012, 33:687-693.
24. Doyle A, Martin WJ, Funa K, Gazdar A, Carney D, Martin SE, Linnoila I, Cuttitta F, Mulshine J, Bunn P, Minna J: Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med 1985, 161:1135.
25. Jäger E, Ringhoffer M, Altmannsberger M, Arand M, Karbach J, Jäger D, Oesch F, Knuth A: Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int J Cancer 1997, 71:142.
26. Degenhardt Y, Huang J, Greshock J, Horiates G, Nathanson K, Yang X, Herlyn M, Weber B: Distinct MHC gene expression patterns during progression of melanoma. Gene Chromosome Cancer 2010, 49:144.
27. Adalsteinsson BT, Gudnason H, Aspelund T, Harris TB, Launer LJ, Eiriksdottir G, Smith AV, Gudnason V: Heterogeneity in white blood cells Has potential to confound DNA methylation measurements. PLoS One 2012, 7:e46705.
28. Koestler DC, Marsit CJ, Christensen BC, Accomando W, Langevin SM, Houseman EA, Nelson HH, Karagas MR, Wiencke JK, Kelsey KT: Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers. Cancer Epidemiol Biomarkers Prev 2012, 21:1293.
29. Lowe R, Rakyan VK: Marmal-aid-a database for Infinium HumanMethylation450. BMC Bioinformatics 2013, 14:359.
30. Rumore PM, Steinman CR: Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J Clin Investig 1990, 86:69.
31. MARMAL-AID. [http://marmal-aid.org/].
32. Thirlwell C, Eymard M, Feber A, Teschendorff A, Pearce K, Lechner M, Widschwendter M, Beck S: Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. Methods 2010, 52:248.
33. R: A language and environment for statistical computing. [http://www.r-project.org/].
34. Bioconductor. [http://www.bioconductor.org/].
35. Bioconductor ChAMP package. [http://www.bioconductor.org/packages/release/bioc/html/ChAMP.html].
36. Smyth GK: Limma. In Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Volume 23. Edited by Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S. New York: Springer; 2005:397-420.
37. Bioconductor Limma package. [http://www.bioconductor.org/packages/release/bioc/html/limma.html].
38. McCarthy DJ, Smyth GK: Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics 2009, 25:765.
39. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B (Methodological) 1995, 57:589.
40. e1071 package. [http://cran.r-project.org/web/packages/e1071/index.html].
41. Koressaar T, Remm M: Enhancements and modifications of primer design program Primer3. Bioinformatics 2007, 23:1289-1291.
42. Li LC, Dahiya R: MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002, 18:1427-1431.
43. Bismark. [http://www.bioinformatics.babraham.ac.uk/projects/bismark/].
44. Bowtie 2. [http://bowtie-bio.sourceforge.net/bowtie2/].
45. Robinson JT, Thorvaldsdottir K, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP: Integrative genomics viewer. Nat Biotechnol 2011, 29:24-26.
46. SAMtools. [http://samtools.sourceforge.net/].
47. ANGSD. [http://popgen.dk/wiki/index.php/ANGSD].
48. Gene Expression Omnibus (GEO). [http://www.ncbi.nlm.nih.gov/geo/].